Balyasny Asset Management
ALHC icon

Balyasny Asset Management’s Alignment Healthcare ALHC Stock Holding History

Balyasny Asset Management’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
93,678
-506,784
-84% -$10.2M ﹤0.01% 1870
2025
Q4 		$11.9M Sell
600,462
-1,030,358
-63% -$18.5M 0.02% 948
2025
Q3 		$28.5M Buy
1,630,820
+882,028
+118% +$13.1M 0.04% 564
2025
Q2 		$10.5M Buy
+748,792
New +$12.1M 0.02% 947
2025
Q1 		– Sell
-48,138
Closed -$542K – 2753
2024
Q4 		$542K Buy
+48,138
New +$563K ﹤0.01% 2170
2024
Q3 		– Sell
-10,442
Closed -$81.7K – 2703
2024
Q2 		$81.7K Buy
+10,442
New +$68.2K ﹤0.01% 2414
2022
Q2 		– Sell
-14,987
Closed -$168K – 2710
2022
Q1 		$168K Buy
+14,987
New +$135K ﹤0.01% 2055

Other funds holding ALHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Balyasny Asset Management's ALHC Position: Q1 2026 in Review

Balyasny Asset Management reduced its Alignment Healthcare (ALHC) stake by 84% in Q1 2026, selling an estimated $10.2M and leaving 93,678 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Balyasny Asset Management first reported a position in ALHC in Q1 2022 and has held it in 7 quarters since. The position peaked at $28.5M in Q3 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Balyasny Asset Management held 93,678 shares of Alignment Healthcare worth $1.65M as of Q1 2026.
  • Balyasny Asset Management sold 506,784 Alignment Healthcare shares in Q1 2026, an estimated $10.2M.
  • Alignment Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1870 holding.
  • Balyasny Asset Management first reported a position in Alignment Healthcare in Q1 2022 and has held it in 7 quarters since.
  • Balyasny Asset Management's Alignment Healthcare position peaked at $28.5M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.